216 related articles for article (PubMed ID: 22095929)
1. Quality of health in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study.
Molgaard-Hansen L; Glosli H; Jahnukainen K; Jarfelt M; Jónmundsson GK; Malmros-Svennilson J; Nysom K; Hasle H;
Pediatr Blood Cancer; 2011 Dec; 57(7):1222-9. PubMed ID: 22095929
[TBL] [Abstract][Full Text] [Related]
2. Pubertal development and fertility in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study.
Molgaard-Hansen L; Skou AS; Juul A; Glosli H; Jahnukainen K; Jarfelt M; Jónmundsson GK; Malmros J; Nysom K; Hasle H;
Pediatr Blood Cancer; 2013 Dec; 60(12):1988-95. PubMed ID: 24038890
[TBL] [Abstract][Full Text] [Related]
3. Renal, gastrointestinal, and hepatic late effects in survivors of childhood acute myeloid leukemia treated with chemotherapy only--a NOPHO-AML study.
Skou AS; Glosli H; Jahnukainen K; Jarfelt M; Jónmundsson GK; Malmros-Svennilson J; Nysom K; Hasle H;
Pediatr Blood Cancer; 2014 Sep; 61(9):1638-43. PubMed ID: 24760750
[TBL] [Abstract][Full Text] [Related]
4. Hearing Status in Survivors of Childhood Acute Myeloid Leukemia Treated With Chemotherapy Only: A NOPHO-AML Study.
Skou AS; Olsen SØ; Nielsen LH; Glosli H; Jahnukainen K; Jarfelt M; Jónmundsson GK; Malmros J; Nysom K; Hasle H;
J Pediatr Hematol Oncol; 2019 Jan; 41(1):e12-e17. PubMed ID: 30550508
[TBL] [Abstract][Full Text] [Related]
5. Treatment-related deaths in second complete remission in childhood acute myeloid leukaemia.
Molgaard-Hansen L; Möttönen M; Glosli H; Jónmundsson GK; Abrahamsson J; Hasle H;
Br J Haematol; 2011 Mar; 152(5):623-30. PubMed ID: 21241281
[TBL] [Abstract][Full Text] [Related]
6. Health status of the oldest adult survivors of cancer during childhood.
Kenney LB; Nancarrow CM; Najita J; Vrooman LM; Rothwell M; Recklitis C; Li FP; Diller L
Cancer; 2010 Jan; 116(2):497-505. PubMed ID: 19908254
[TBL] [Abstract][Full Text] [Related]
7. [Allogenic transplantation of hematopoietic stem cells in the treatment of children with high-risk acute leukemia].
Starý J; Kobylka P; Sedlácek P; Komrska V; Vávra V; Syrůcková Z; Smísek P; Hrubá A; Korínková P; Matĕjková E; Cukrová V; Dolezalová L; Loudová M; Sejkorová J; Kvĕch J
Cas Lek Cesk; 1998 Jun; 137(12):363-7. PubMed ID: 9721472
[TBL] [Abstract][Full Text] [Related]
8. [Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children].
Reinhardt D; Hempel G; Fleischhack G; Schulz A; Boos J; Creutzig U
Klin Padiatr; 2002; 214(4):188-94. PubMed ID: 12165900
[TBL] [Abstract][Full Text] [Related]
9. Late effects in long-term survivors after treatment for childhood acute leukemia.
Haddy TB; Mosher RB; Reaman GH
Clin Pediatr (Phila); 2009 Jul; 48(6):601-8. PubMed ID: 19264722
[TBL] [Abstract][Full Text] [Related]
10. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
[TBL] [Abstract][Full Text] [Related]
11. Disability and health-related quality of life in long-term survivors of cancer in childhood in Brazil.
Shimoda S; Horsman J; Furlong W; Barr R; de Camargo B
J Pediatr Hematol Oncol; 2008 Aug; 30(8):563-70. PubMed ID: 18799931
[TBL] [Abstract][Full Text] [Related]
12. High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation.
Cesaro S; Meloni G; Messina C; Pillon M; Proglia A; Lanino E; Caniggia M; Bagnulo S; Pession A; Locatelli F;
Bone Marrow Transplant; 2001 Jul; 28(2):131-6. PubMed ID: 11509930
[TBL] [Abstract][Full Text] [Related]
13. Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A.
Creutzig U; Büchner T; Sauerland MC; Zimmermann M; Reinhardt D; Döhner H; Schlenk RF
Cancer; 2008 Feb; 112(3):562-71. PubMed ID: 18076087
[TBL] [Abstract][Full Text] [Related]
14. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
[TBL] [Abstract][Full Text] [Related]
15. Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003.
Molgaard-Hansen L; Möttönen M; Glosli H; Jónmundsson GK; Abrahamsson J; Hasle H;
Br J Haematol; 2010 Dec; 151(5):447-59. PubMed ID: 20955398
[TBL] [Abstract][Full Text] [Related]
16. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.
Creutzig U; Zimmermann M; Reinhardt D; Dworzak M; Stary J; Lehrnbecher T
J Clin Oncol; 2004 Nov; 22(21):4384-93. PubMed ID: 15514380
[TBL] [Abstract][Full Text] [Related]
17. Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group.
Tsukimoto I; Tawa A; Horibe K; Tabuchi K; Kigasawa H; Tsuchida M; Yabe H; Nakayama H; Kudo K; Kobayashi R; Hamamoto K; Imaizumi M; Morimoto A; Tsuchiya S; Hanada R
J Clin Oncol; 2009 Aug; 27(24):4007-13. PubMed ID: 19620491
[TBL] [Abstract][Full Text] [Related]
18. Long-term health outcomes in survivors of childhood AML treated with allogeneic HSCT: a NOPHO-AML Study.
Wilhelmsson M; Glosli H; Ifversen M; Abrahamsson J; Winiarski J; Jahnukainen K; Hasle H;
Bone Marrow Transplant; 2019 May; 54(5):726-736. PubMed ID: 30242226
[TBL] [Abstract][Full Text] [Related]
19. Health conditions and quality of life in survivors of childhood acute myeloid leukemia comparing post remission chemotherapy to BMT: a report from the children's oncology group.
Schultz KA; Chen L; Chen Z; Kawashima T; Oeffinger KC; Woods WG; Nicholson HS; Neglia JP
Pediatr Blood Cancer; 2014 Apr; 61(4):729-36. PubMed ID: 24285698
[TBL] [Abstract][Full Text] [Related]
20. High health-related quality of life among long-term survivors of childhood acute lymphoblastic leukemia.
Harila MJ; Salo J; Lanning M; Vilkkumaa I; Harila-Saari AH
Pediatr Blood Cancer; 2010 Aug; 55(2):331-6. PubMed ID: 20582965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
